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ABSTRACT: Microencapsulation of cells in hydrogel-based porous matrices
is an approach that has demonstrated great success in regenerative cell
therapy. These microcapsules work by concealing the exogenous cells and
materials in a robust biomaterial that prevents their recognition by the
immune system. A vast number of formulations and additives are
continuously being tested to optimize cell viability and mechanical properties
of the hydrogel. Determining the effects of new microcapsule additives is a
lengthy process that usually requires extensive in vitro and in vivo testing. In
this paper, we developed a workflow using nanoindentation (i.e., indentation
with a nanoprobe in an atomic force microscope) and a custom-built
microfluidic constriction device to characterize the effect of graphene oxide
(GO) on three microcapsule formulations. With our workflow, we determined that GO modifies the microcapsule stiffness and
surface properties in a formulation-dependent manner. Our results also suggest, for the first time, that GO alters the conformation of
the microcapsule hydrogel and its interaction with subsequent coatings. Overall, our workflow can infer the effects of new additives
on microcapsule surfaces. Thus, our workflow can contribute to diminishing the time required for the validation of new microcapsule
formulations and accelerate their clinical translation.
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1. INTRODUCTION
In the past few decades, regenerative cell therapy has
demonstrated encouraging successes in the treatment of
many diseases, using approaches such as cell encapsulation.1,2
Cell encapsulation aims to immobilize cells within a hydrogel-
based porous micro- or macrosphere that allows nutrients to
diffuse inside and therapeutic products (e.g., insulin and
erythropoietin) to be secreted outside, while avoiding the
immune system surveillance.3 The effectiveness of cell
encapsulation relies on the successful concealing of exogenous
cells and materials, which requires adequate mechanical
resistance to prevent microcapsule rupture and the subsequent
content release.4 Currently, the main challenges of micro-
encapsulated cell therapy include the accumulation of dead
cells inside the microcapsules and the optimization of the
sustained product release from encapsulated cells to achieve
long-lasting treatments.4,5 To overcome these challenges,
classical microcapsule formulations have been supplemented
with additives or coatings, thereby modifying microcapsule
properties (i.e., hybrid microcapsules).6 Specifically, the
combination of graphene oxide (GO) and microencapsulation
technology has shown to improve the long-term alginate-
encapsulated cell survival and sustainable therapeutic protein
release,7 without triggering a foreign body response.4
GO is used in a wide range of biological applications (e.g.,
drug delivery, tissue engineering, and biosensing).8−11 One of
the reasons behind the popularity of GO as an additive is its
excellent mechanical properties.12 Specifically, GO has been
shown to improve the tensile strength of porous biomaterials
without modifying their pore size or thickness,13 which is
crucial for maintaining the diffusivity of nutrients into the
capsules and keep encapsulated cells viable.14 Interestingly, low
concentrations of GO have been reported to increase the
viability of encapsulated cells.7 Although the incorporation of
GO in new microcapsule formulations may be advantageous
for cell viability, questions remain on the potential effects of
GO on the alginate hydrogel structure and resulting
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mechanical properties. The effects of new additives are of
particular importance on the microcapsule surface, where the
interactions between the host cells and the microcapsule
material occur. As discussed previously, unstable outermost
interfaces of microcapsules can have a profound impact on
performance and biocompatibility.15 Therefore, to refine
formulations prior to in vivo testing and advance regenerative
cell therapy more quickly, it is critical to develop techniques to
characterize the mechanical and surface properties of newly
designed microcapsule formulations.
Previous studies have used infrared spectrophotometry by
Fourier transform−attenuated total reflectance (ATR−FTIR)
to characterize the effects of hybrid microcapsule compositions
on surface polymer conformations. However, this technique
provides an insight within a small depth of the microcapsule
(100 Å) and remains challenging to interpret.16 Scanning
electron microscopy (SEM) is a valuable technique to
characterize surfaces. However, most SEM sample preparation
procedures modify the hydrogel structure, thereby providing
inaccurate surface characterizations.17 Conversely, atomic force
microscopy (AFM) is a powerful set of techniques for the
characterization of surface properties of materials, which does
not rely on sample modifications.18−20 Lately, a small number
of studies have used AFM to characterize microcapsule
surfaces under liquid physiological environments.14,21−23 The
nanometric resolution of AFM can provide accurate data of the
microcapsule surface topography along with local stiffness
measurements at the surface level.24 In previous work, we used
a popular and powerful AFM technique to acquire
simultaneous topography and stiffness maps of the micro-
capsule cal led force spectroscopy-based imaging
(FSBI).22,25−28 Variations of this technique have been used
since before the 2000s by Hinterdorfer and others to produce
quantitative nontopography images of antibody−antigen
recognition forces, among other molecular interactions and
physical properties.28−32 In our previous paper, we leveraged,
for the first time, FSBI along with a stiffness−topography
colocalization analysis to investigate the effects of microcapsule
additives on the polymer conformation. This combination of
techniques provided us with useful information on the surface
properties of the microcapsules, but this alone is not enough to
determine the microcapsule’s overall stiffness. In addition,
stiffness determination via nanoindentation is useful only for
small strains, whereas hydrogel microcapsules are often
subjected to large strains.
Microcapsules are subjected to high shear stresses and
considerable strains, as they are forced to go through a rigid
needle in the injection process.33 Excessive shear stress may
result in microcapsule breaking and thereby releasing its
contents, which could elicit an immune response.34 Although
AFM is a sensitive technique for characterizing topography and
surface stiffness,23 assessing global stiffness calls for a different
approach, especially for the large strains exerted in the
injection process. Shear stress application assays via micro-
manipulation, aspiration, or constriction have been used to
investigate the overall stiffness of microcapsules.35−37 Exper-
imental determination of stiffness for large deformations is not
trivial because of the inelastic behaviors of the material and
uneven compressions arising from the spherical geometries.33
However, a constriction test (i.e., forcing the capsules to pass
through a narrow channel) can be used to approximate
pressure/deformation relationships to compare different
microcapsule compositions,38 as a complementary set of
measurements to FSBI-based surface topography and stiffness.
Herein, we used two complementary methods for the
characterization of hybrid microcapsule formulations. First, we
used FSBI to analyze the effects of GO on surface features and
mechanical properties of three different alginate-based micro-
capsules. In particular, we tested the effects of GO on alginate
microcapsules (A), alginate microcapsules with a double poly-
L-lysine (PLL)−alginate coating (alginate−PLL−alginate,
APA), and liquefied APA microcapsules (i.e., treated with
sodium citrate to produce a softer capsule).39 Using FSBI, we
characterized the topography of the microcapsule surface and
the stiffness at the surface level. In parallel, we also developed a
custom-designed constriction test to perform global stiffness
measurements of the microcapsules. Finally, we established
correlations between topography and surface stiffness to
determine the effects of GO on the microcapsule surface and
polymer conformation. Our results show that the effect of GO
Figure 1. Schematic representation of the FSBI methodology. (A) Microcapsules were immobilized within a nylon mesh to acquire the (B)
spectroscopy-based measurements via AFM. (C,D) Force spectroscopy-based grids were acquired for each microcapsule and processed to obtain
both (C) a topography and (D) a stiffness map of the same microcapsule surface area. (E) Schematic representing the characterization of
bidimensional statistical quantities for the topography images. (F) Overlays of topography and stiffness maps were generated to determine the
colocalization degree of both parameters. (G) Stiffness measurements obtained via FSBI were compared to macroscopic measurements via
constriction assays with a custom-designed microfluidic system.
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depends on the microcapsule formulation. Particularly, our
results suggest that GO modifies the stiffness−topography
distribution, thereby suggesting that GO alters the conforma-
tion of the alginate hydrogel, as well as coating binding to
alginate. The workflow comprising these two techniques (FBSI
and microcapsule constriction) can be used to assess the
mechanical properties resulting from hybrid microcapsule
formulations in vitro. We anticipate that the use of these two
techniques, in combination, will help accelerate microcapsule
formulations and, eventually, their use in clinical applications.
2. RESULTS AND DISCUSSION
This study was motivated by previous work from us and others,
indicating that supplementing microcapsules with GO particles
within a limited size (1535.33 + 435.31 nm) and concentration
range (25−50 μg/mL) could be beneficial in keeping high cell
viability of encapsulated cells and did not have a negative
impact on the viability of implanted microcapsules.4,7,14
We characterized the microcapsule surface features by FSBI
to analyze the effects of GO on the surface of alginate-based
hybrid microcapsules. To this end, we used nanoindentation
measurements, performed at 37 °C in liquid (DPBS), to mimic
physiological conditions after microcapsule implantation. The
microcapsules were immobilized in a nylon mesh, thereby
avoiding sample preparation techniques that may damage the
original structure and properties of the microcapsules (Figure
1A). Each force spectroscopy curve was acquired within a grid
and corresponded to a pixel (Figure 1B), thereby generating
map images of the microcapsule surface (Figure 1C). On the
one hand, topography map images (gold) were obtained by
depicting the height values calculated from the force
spectroscopy measurements. On the other hand, the same
force spectroscopy curves were fitted to a Hertz model,
yielding Young’s modulus values that rendered stiffness map
images (blue). These FSBI maps were then analyzed to
characterize microcapsule topographical (Figure 1E) and
mechanical properties (Figure 1F,G).
Accurate Hertz model fittings to calculate Young’s moduli
require specific types of tip conformations (e.g., spherical,
quadratic pyramid, and conical).40,41 Notably, our choice of
cantilever shape was quadratic pyramid, as opposed to the
most popular one for hydrogel measurements but more costly
colloidal/spherical tips. In our case, pyramid-shaped tips were
chosen because of their potentially higher stability in
measuring spherical samples, as well as their much lower
cost, which was more convenient for our large sample size.
Importantly, our study illustrates that a more affordable tip
shape can be successfully used to acquire stable topographies
and curves that fit Hertz model variations successfully.
To determine the effect of GO in hybrid microcapsules, we
studied three microcapsule formulations: basic alginate (A)
microcapsules, classical alginate−poly-L-lysine−alginate micro-
Figure 2. Schematic of the three different microcapsule formulations and their GO-supplemented counterparts with representative microcapsule
topography images of each one acquired via FSBI. Alginate microcapsules are produced by extrusion of an alginate solution in an electrostatic
atomization generator. These microcapsules are treated first with a poly-L-lysine coating and second with an alginate coating to produce APA
microcapsules. APAliq microcapsules are obtained by incubating APA microcapsules in a sodium citrate solution. To obtain their GO-
supplemented counterparts, the initial alginate solution is supplemented with 100 μg/mL GO. Topography images (9 μm2) of each microcapsule
were acquired to analyze topographical differences resulting from the different microcapsule compositions. Height scale bars are adjusted to
optimize the visualization of topography details.
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capsules (A−PLL−A or APA), and APA microcapsules
liquified via sodium citrate treatment (APAliq). For each
microcapsule composition type, 100 μm2 topography maps
(Figure S1) and 9 μm2 topography maps (Figures 2 and S2)
were collected. Larger images inform the homogeneity of
microcapsule topography, whereas smaller view images provide
enough resolution to capture topography features. Therefore,
the analysis was performed with the 9 μm2 topography maps
alone. Qualitatively, topographic maps of control and GO-
supplemented capsules did not seem different from each other.
Conversely, topographic maps of coated (i.e., APA and
APAliq) microcapsules appear different from naked alginate
(A) microcapsules. More specifically, alginate (A) capsules
presented a higher prevalence of thick peaks and extensive
valleys. The appearance of the surface was consistent with
previous reports of the topography of the alginate cross-linked
network structure.42,43 Conversely, in APA and APAliq
microcapsules, the surface presented a porous structure,
consistent with features expected from the alginate−PLL
coating.21,22
To perform a more exhaustive analysis of the effects of GO
on microcapsule topography, bidimensional statistical quanti-
ties were calculated from all FSBI topography maps (Figure 3):
Ra, RMS, maximum image height (MaxIH), median image
height (MedIH), and skewness.44,45
We first investigated surface roughness by calculating Ra
(Figure 3A) and RMS (Figure 3B) parameters. Both
parameters calculate deviations of the surface from a flat
plane. Ra calculates this deviation as the distance that the
surface of interest deviates from a flat plane, whereas RMS
calculates the deviations as the area enclosed by these two
components (Figure 3C).46 A two-way analysis of variance
showed that Ra and RMS are independently affected by both
microcapsule formulation and GO. Hence, roughness is
significantly influenced by microcapsule composition (Ra:
F(2,34) = 33.39 and P < 0.001; RMS: F(2,34) = 48.99 and P <
Figure 3. Topographical study of microcapsule surfaces. Standard topography parameters calculated from topography maps (9 μm2) of
microcapsules. (A,B) Graphs showing roughness parameters: (A) Ra and (B) RMS, (C) Schematic representation of the significance of Ra and
RMS on an example line profile. (D,E) Graphs showing image height parameters. (D) Maximum image height, (E) median image height, and (F)
schematic representation of maximum and median image height on an example line profile. (G) Graph showing skewness, a measurement of height
distribution in an image. (H,I) Schematic representations of (H) high and (I) low skewness on an example line profile. N ≤ 5 samples per
microcapsule composition. Graphs show mean ± SEM. Two-way ANOVA showed independence between GO effects and microcapsule
formulation effects on roughness and height distribution, while it showed interdependence of these effects on height parameters. Sidak’s multiple
comparisons tests were used to compare GO versus control capsules and each formulation versus A. * = significance of GO versus control capsules.
# = significance compared to A microcapsules. *p < 0.05; **p < 0.01; ***p < 0.001.
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0.001) (a more detailed explanation of the two-way ANOVA
results can be found in Figure S3). In particular, coated
microcapsules present smaller values of Ra and RMS than A
microcapsules. As previously suggested, the coating seems to
have a smoothing effect on the microcapsule surface.22
Meanwhile, GO increases surface roughness in supplemented
microcapsules (Ra: F(1,34) = 8.564 and P = 0.006; RMS:
F(1,34) = 8.067 and P = 0.008).
Next, we assessed the height distributions of our topography
maps by calculating MaxIH and MedIH. MaxIH (Figure 3D),
or surface amplitude, is the absolute distance between the
lowest and the highest point of the surface map, whereas
MedIH (Figure 3E) corresponds to the most prevalent height
value throughout the surface. Therefore, MedIH can be
understood as the surface baseline from which peaks and
valleys emerge (Figure 3F). Consistent with roughness results,
both MaxIH and MedIH are affected by microcapsule
formulation (MaxIH: F(2,34) = 156.7 and P < 0.001;
MedIH: F(2,34) = 53.22 and P < 0.001). We found that
coated microcapsules have lower height values than A
microcapsules, consistent with a flattening effect of the coating.
However, the addition of GO produces the opposite effect,
increasing MedIH and MaxIH of the microcapsule surfaces
(MaxIH: F(1,34) = 8.211 and P = 0.007; MedIH: F(1,34) =
23.88 and P < 0.001). Interestingly, there is an interaction
between the microcapsule formulation and the addition of GO
in both height parameters (MaxIH: F(2,34) = 13.01 and P <
0.001; MedIH: F(2,34) = 10.85 and P < 0.001). Overall, we
observed that GO increases height preferentially in coated
capsules, with no effect on the already irregular surface of
naked A capsules. Notably, MaxIH in APAliq microcapsules
was unaffected by the addition of GO, which could be
explained by the citrate treatment on the surface of the
microcapsule, resulting in flatter surfaces in both control and
GO-supplemented capsules.
The last bidimensional statistical quantity we analyzed was
skewness (Figure 3G). Skewness is an indicator of the surface’s
irregularity and represents the symmetry (or lack thereof) of
the height distribution compared to half of the MaxIH (Figure
3H,I). It is important to note that differences in skewness are
calculated according to the height of each image. We found
that this parameter was strongly dependent on microcapsule
Figure 4. Representative microcapsule stiffness maps obtained by FSBI. (A) Topography and Young’s modulus distribution maps (9 μm2) of each
microcapsule were acquired to establish topography−stiffness colocalization differences between microcapsule compositions. Sample images for
alginate and A GO capsules are depicted, including topography and stiffness maps and overlays (green = stiffness, red = topography, and yellow =
colocalizing structures). (B−D) Pearson’s correlation coefficients were calculated using the van Steensel method for all capsules. Each GO-
supplemented microcapsule formulation was compared to its control counterpart. (B) Pearson’s correlation coefficient comparisons of A vs A GO,
(C) APA vs APA GO, and (D) APAliq versus APAliq GO microcapsules. (E) Schematic representation of all microcapsule formulations with their
assigned color code. (F) Degree of colocalization presented as the Pearson coefficient at x = 0 from graphs (B−D) for comparison among
formulations. Significant differences between each pair of compared formulations were calculated via one-way ANOVA and post hoc Tukey test. *
= significance of GO vs control microcapsules. § = significance compared to 0. **p < 0.01; ***p < 0.001.
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formulation (F(2,34) = 28.07 and P < 0.001). Notably, A
microcapsules showed the highest skewness values, suggesting
that naked surfaces were mostly asymmetrical (i.e., presenting
more peaks and shallow valleys), which is consistent with our
initial observations (Figure 2). Conversely, coated micro-
capsules presented valleys with a smaller diameter and more
discrete peaks. Overall, although we did not see differences
between control and hybrid microcapsules, a two-way analysis
revealed that the addition of GO resulted in a more skewed
down surface (F(1,34) = 12.39 and P = 0.001) regardless of
microcapsule formulation.
In previous work, we investigated the colocalization of
simultaneously acquired topography and stiffness maps to
study alginate chain-coating interactions on the microcapsules’
surface.22 Reportedly, GO has excellent mechanical properties
(i.e., presents a high Young’s modulus), which could disrupt
the typical conformation of the softer alginate and PLL
components of the microcapsules.47 In this study, top-
ography−stiffness colocalizations could inform the location
of GO within the microcapsule and its effect in the alginate
conformation on the surface. Hence, for each topographical
map collected, we also obtained its stiffness counterpart via
Hertz model fitting of each force spectroscopy curve (Figures
S4 and S5 for 100 and 9 μm2 maps, respectively). Mean values
of these stiffness maps were calculated (Figure 6) to compare
surface stiffness of each microcapsule formulation.
With these data, we first studied whether the GO added to
the microcapsules was located close enough to the surface to
detect it via FSBI. To do so, we determined the Young’s
modulus for GO in our system by performing the FSBI
technique on GO from the suspension used to supplement our
microcapsule formulations (Figure S6), under the same
conditions as used for microcapsules. If GO is located close
to the microcapsule surface, higher stiffness values would be
measured via FSBI than in the control formulations. Although
the low cantilever stiffness may not be ideal to determine the
absolute stiffness values of GO, it provides an accurate control
to determine the presence of GO in microcapsules. The
stiffness values of GO (1.19 ± 0.812 × 104 kPa) were over 40-
fold above the maximum values of APA GO microcapsules
(Figures S3 and S4), which presented the highest stiffness in
our study. Furthermore, GO-supplemented formulations were
less stiff than their control counterparts. Hence, we concluded
that GO was not within a detectable range of the surface for
our technique.
Then, we investigated the effect of GO on the topography−
stiffness correlation of our microcapsule formulations. Thus,
we overlaid topography (gold) and stiffness (blue) maps
(Figure 4A; sample stiffness maps in Figures S3 and S4) from
the same region. Using the Van Steensel method, we calculated
Pearson’s correlation coefficient for each pair of microcapsule
formulations (i.e., control and GO-supplemented) (Figure
4B−F). Control formulations presented significant stiffness−
topography colocalization (i.e., the peaks in topography were
stiffer than the rest of the surface). However, we observed that
the presence of GO significantly changed the degree of
colocalization of the control formulations (F(2,44) = 85.77
and P < 0.001). Interestingly, the overall effect and direction of
this disruption depended on the microcapsule formulation
(F(2,44) = 67.62; P < 0.001). Particularly, in the alginate (A)
microcapsules, the addition of GO resulted in a higher degree
of colocalization between topography and stiffness. In other
words, the topography peaks corresponded more precisely to
stiffer regions of the GO-supplemented microcapsule surfaces.
Figure 5. Microcapsule constriction assay. (A) Graphic depiction of the constriction system set up. (B) Scheme of the constriction assay process
and parameters needed for calculating our elastic constant: initial diameter (indicated as D) of every microcapsule and penetration length
(indicated as L) are optically measured. At the same time, the pressure controller sets pressure (marked as P) at the inlet. (C) Microscopy images
(Leica) of a microcapsule constriction assay. Hematoxylin stain of the microcapsule for visualization purposes.
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Conversely, in APA and APAliq formulations, the addition of
GO significantly decreased the microcapsules’ stiffness−
topography colocalization. Surprisingly, the colocalization
degree in APAliq was close to zero, indicating no top-
ography−stiffness correlation, whereas in APAliq GO, the
colocalization values were negative (i.e., the topography peaks
and stiffness peaks did not coincide with each other).
These results indicate that the presence of GO disrupts the
polyanionic alginate matrix significantly on the surface, even
though the FSBI does not directly detect the GO. Notably, this
decrease in degree of colocalization appears in the two coated
formulations (i.e., APA and APAliq). This result could indicate
that microcapsules with subsequent coatings or treatments
presented a looser attachment between the coatings and the
polyanionic matrix.
Finally, we analyzed the effect of GO on microcapsule
stiffness. However, FSBI is based on nanoindentation, and
thus, it provides only surface measurements and for small
deformations. Therefore, we assessed global average stiffness
via a custom-made constriction assay (schematic in Figure 5A).
In this assay, microcapsules in a DPBS solution were forced to
pass through a narrow channel. This assay mimics the shear
stress inflicted on microcapsules during the implantation
process, and stiffness is calculated as a pressure-deformation
ratio (Figure 5B,C). The average stiffness results from this
constriction assay were compared to the median value of
stiffness maps obtained via nanoindentation (Figure 6).
The constriction of microcapsules through a smaller tube is a
complex mechanical problem. Microcapsule constriction incurs
in a wide range of strains and stresses, generating substantial
deformations throughout the microcapsule geometry and with
a high variation throughout its geometry. Although the elastic
modulus is commonly used in mechanical problems where
small strains are applied (e.g., nanoindentation), speaking of
pressure-deformation ratios in terms of elastic modulus is
inaccurate, because a great variety of tangent moduli, which
could be considered as the strain-dependent Young’s modulus
counterpart, are simultaneously produced pointwise. Only a
comprehensive simulation of the whole process (e.g., via finite
elements and parameter fitting of the material constants for the
microcapsules) would accurately define the microcapsule
stiffness, without considering the inhomogeneity induced by
GO distribution. However, because our main goal is to
compare the relative stiffness between different types of
microcapsules, the proposed pressure-deformation ratio, which
averages the microcapsule stiffness through the first state of the
constriction process, is sufficient for our purpose. Thus, our
comparisons between both stiffness measurements (Figure 6)
will not rely on comparing absolute values but tendencies
among the different formulations.
Our first observation in comparing the stiffness of the
different formulations was the high stiffness of APA capsules
via FSBI as compared to all other formulations, which was not
observed in the constriction measurements. This difference
highlights the difference between both techniques. In other
words, although FBSI is only measuring surface stiffness, the
constriction assay produces a more macroscopic measurement
of stiffness and for larger strains. Despite these striking
differences, both techniques (i.e., FSBI and constriction)
revealed a decrease in stiffness in GO-supplemented
formulations (FSBI: F(1,59) = 20.34 and P < 0.001;
constriction: F(1,65) = 32.60 and P < 0.001). Furthermore,
the effect of GO strongly depends on the microcapsule
formulation (FSBI: F(2,59) = 32.16 and P < 0.001;
constriction: F(2,65) = 46.78 and P < 0.001).
Particularly, the stiffness of the APA GO formulation was
significantly decreased compared to that of APA, although it
remained significantly stiffer than the other formulations. This
result illustrates the high local stiffness of the classical APA
design on the surface and suggests a significant impact of GO
in the surface stiffness of this formulation. Although the impact
of GO in stiffness is clear in both sets of measurements, it is in
the APA formulation where the impact of GO was more
prominent. This result is consistent with the hypothesis that
both the bulk hydrogel and the coatings are impacted by the
addition of GO. Interestingly, the decrease in stiffness in
APAliq GO as compared to its control counterpart was not
detectable via FBSI, which suggests that the main effect of GO
in decreasing the stiffness of APAliq formulations occurs in the
bulk of the alginate hydrogel, rather than on the surface. Also,
most likely, its effect is more pronounced for higher local
deformations of the polymer.
For this study, we chose to keep our cantilever measure-
ments consistent by performing all of our FSBI measurements
with the same type of cantilever. A caveat for using only one
type of cantilever for the FSBI measurements is found in the
stark differences between APA/APA GO formulation stiff-
nesses as compared to all other formulations. It is known that
cantilevers perform best for samples in a specific range of
stiffness; therefore, the top stiffness values may not be accurate
measurements. In this study, we aimed to compare the
different formulations to one another. Future studies could
provide an accurate measurement of stiffness for these
microcapsule formulations or the GO particles themselves
using a stiffer cantilever to perform the FSBI.
Overall, in this paper, we determined that GO induced
changes in all microcapsule formulations (summary in Table
1). The effect of GO on naked alginate capsules (A) was
limited to a higher degree of colocalization between top-
ography and stiffness, indicating that peaks were stiffer in the A
GO formulation (dark blue color, Figure 7, left). Conversely,
in both APA and APAliq formulations, there were significant
changes in topography, namely, the increases in MaxIH (in
Figure 6. Results of microcapsule stiffness analysis. (Left) Young’s
modulus values obtained from stiffness maps via nanoindentation
(force spectroscopy) of the microcapsule surface. n ≤ 5 per
microcapsule composition group, from two different batches of
microcapsules. (Right) Whole microcapsule constriction stiffness as a
pressure-deformation ratio obtained from constriction assay. n = at
least 10 per formulation. Graphs represent mean values ± SEM. The
unpaired t-test was used to compare GO vs control capsules and each
formulation vs A. * = significance of GO versus control capsules. # =
significance compared to A microcapsules. *p < 0.05; **p < 0.01;
***p < 0.001.
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APA alone) and MedIH (in both APA and APAliq) (Figure 7,
center and right). The increase in MedIH is also consistent
with the increase in surface roughness. Interestingly, the
skewness (i.e., height distributions in the z direction) of these
formulations did not change as a result of the addition of GO.
These two formulations also experienced a lower degree of
colocalization between topography and stiffness, indicating that
peaks were softer on both GO-supplemented formulations
than in their control counterparts. This effect may be explained
by a detachment of the PLL−alginate coating from the bulk
alginate hydrogel. As we described in the previous section, GO
had no effect on the stiffness of A capsules. Conversely, GO
induced a weakening effect in the overall capsule of APA and
APAliq. FSBI only detected a decrease in stiffness in APA GO
versus APA microcapsules, suggesting that this weakening
effect translated only to the surface of this formulation.
Furthermore, our results indicate that subsequent modifica-
tions magnify the impact of GO on the surface topography and
stiffness.
The impact of GO is consistent with our previous
hypothesis, indicating that GO may be disrupting the typical
alginate network structure. An explanation of the disruption of
the alginate matrix could reside on the negative surface charge
exhibited by GO.48 Alginate microcapsules form a gel as a
consequence of the ionic cross-linking of alginate chains and
dicationic calcium.49 However, this electric charge equilibrium
may be disturbed by GO, thereby changing the nature of the
alginate polymer. Interestingly, the effect of GO seems to be
more detectable in formulations with subsequent modifications
or coatings. Next, we observed that the differences in
topography were not significant in naked formulations, while
they were significant in both APA and APAliq formulations.
This increase in disorder with subsequent coatings is consistent
with observations reported in our previous work.22
The effect of the liquefaction treatment on APAliq surfaces
remains poorly described, and therefore, an in-depth
interpretation of the effects of GO in this formulation remains
challenging. However, our results show that this treatment
generates profound differences in the alginate−PLL con-
formation. Although further investigation (e.g., z-potential
measurements and ATR−FTIR) may be needed to elucidate
the chemical modifications behind the topography and stiffness
changes that we observed after the supplementation with GO,
careful consideration of the adequacy of new formulations for
each application is warranted.
Overall, we determined that GO has a detrimental effect on
microcapsule stiffness. As for the significance of our findings,
more compliant microcapsules would indicate a higher
flexibility, and therefore, more highly adaptable microcapsules
pass through a narrow needle during the implantation process.
On the other hand, it is considered that a less robust
microcapsule may release microcapsule contents and elicit an
immune response. Therefore, care must be taken when
subjecting GO-supplemented microcapsules to high shear
stresses. In future studies, rupture pressures of microcapsules
could be assessed to determine the impact of GO on this
parameter. Another interesting point would be the effect of
stiffer matrices on encapsulated cells. Matrix stiffness is known
to impact cell function,50,51 while cell viability actually
increased in GO-supplemented capsules,4 and the effects of
stiffness on therapeutic product efficacy and secretion
efficiency would be an interesting topic for future studies.
An increase in peak height or roughness in microcapsule
surfaces has been discussed less in the literature. Such surface
modifications are potentially disadvantageous for micro-
capsules for two reasons: (1) a larger surface of contact for
microcapsules translates into more area for potential cell−
microcapsule interactions and therefore a higher potential for
graft rejection and (2) there is evidence that an increase in
roughness in biocompatible materials modifies cell adhesion
and behavior. Further studies will need to be performed to
determine whether the differences we detected using our
workflow translate into significant disadvantages in vivo.
3. CONCLUSIONS
Microencapsulation is a promising approach to conceal cells
from the host’s immune system in cell-based therapy.
However, a few hurdles remain for the full implantation of
this technology in the clinic. Namely, the stability of the
microcapsules to high shear stresses and guaranteeing a high
cell variability are areas of current interest in the field of
microencapsulation. The use of hybrid microcapsules has
recently demonstrated to be successful in fulfilling these needs.
Unfortunately, the success of the formulation is often found
only after in vivo implantation, a costly and time-consuming
process.
Table 1. Summary of the Effects of GO on A, APA, and












roughness - increase increase











surface stiffness - decrease -
overall stiffness - decrease decrease
Figure 7. Proposed model of the surfaces of microcapsules before and
after GO supplementation for alginate alone (A), APA, and APAliq
microcapsules. A (alginate alone) microcapsules were less affected by
the addition of GO, whereas APA formulations presented higher
topographic features and weaker bulk hydrogels. Finally, APAliq
microcapsules presented higher topographic features and a detach-
ment of the PLL coating from the liquified alginate matrix.
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In particular, the addition of GO to new microcapsule
formulations has demonstrated potential in increasing cell
viability without eliciting a foreign body response in vivo. Our
results confirm changes in the mechanical properties of
microcapsules as a result of including GO in microcapsule
formulations. Importantly, although GO had an impact on the
stiffness of microcapsules, it did not result in less stable
formulations. Rather, once basic stability of microcapsules is
achieved, GO-supplemented microcapsules may be more
compliant to deformation and resilient to injection-related
shear stress.
In this article, we used a workflow comprising FSBI and a
constriction assay to uncover potential effects of GO on the
microcapsule surfaces. Interestingly, we determined via FSBI
that although GO is not located close to the microcapsule
surface, it has an effect on the conformation of the alginate
network, which becomes more apparent with subsequent
coatings and surface modifications. Along with FSBI, our
custom-made constriction assay could help in determining
optimal microcapsule formulations to resist high stresses
through the implantation process.
The use of this workflow to characterize the changes
generated on the microcapsule surface as a result of changes in
formulation could significantly shorten the time needed to
validate each new formulation, along with costs, before testing
them in vivo. Overall, we anticipate that our workflow will be
used in the future as a tool to aid rational microcapsule design
and help accelerate microencapsulation research and its clinical
translation.
4. MATERIALS AND METHODS
4.1. Microcapsule Preparation. Microcapsules were generated
following an adapted protocol to that of Lim and Sun.14,52 Briefly,
procedures were carried out at room temperature under aseptic
conditions. Mannitol (Sigma-Aldrich, M4125, Madrid, Spain) was
dissolved at 1% in distilled water. Unless specified otherwise,
subsequent solutions were prepared in this 1% mannitol aqueous
solution. Ultrapure low viscosity high Guluronate, UPLVG, alginate
(SKU: 4200001, NovaMatrix, FMC Biopolymer, Norway) was
resuspended at final concentrations of alginate of 1.87, 1.5, and
0.1%. Solutions were sterilized with a 0.22 μm syringe filter
(Millipore, MA, USA). Alginate solutions (1.5%) were extruded in
the electrostatic atomization generator VARV1 (Nisco, Switzerland)
with a peristaltic pump (flow rate: 5.9 mL·h−1). The resulting
microcapsules (A, or alginate alone) were collected in 55 mM CaCl2
(Sigma-Aldrich, Madrid, Spain) and incubated for 15 min in agitation
to allow for complete gelation.
A + GO: To produce A capsules with GO, a 1.87% alginate
solution with GO was used instead of the 1.5% alginate alone
solution. To generate this solution, GO (Graphenea, Spain) was
suspended in Milli-Q water at 250 μg/mL and sonicated for 1 h at
high intensity. GO suspension was diluted to 1:5 (V/V) with 1.87%
alginate solution to produce a 1.5% alginate solution and 100 μg/mL
GO. Both “A” and “A GO” were washed and coated according to the
desired microsphere formulation:
APA is a classical alginate−PLL−Alginate (PLL = poly-L-lysine
hydrobromide Mw 15−30 kDa) (Sigma-Aldrich, St. Louis, MO, USA)
design. To produce these microcapsules, A microcapsules were
incubated in a 0.05% (w/v) PLL solution with agitation for 5 min,
followed by a second 0.1% alginate coating for another 5 min.
Finally, to generate liquefied APA microcapsules (APAliq), APA-
collected microcapsules were incubated in a 1.5% sodium citrate in
1% mannitol solution with agitation for 10 min, as previously
described.39 All microcapsules were finally washed twice with DPBS
with calcium and magnesium (Sigma, D8662) and maintained in
DPBS with Ca and Mg. Resulting microcapsule preparations were A,
A GO, APA, APA GO, APAliq, and APAliq GO. Microcapsule
morphology and diameter were examined under an inverted optical
microscope (Nikon TSM, Japan).
4.2. AFM Setup and Measurements. Topographic and
mechanical characterization of the microcapsules was performed by
AFM (JKP Instruments). A Nanowizard 3 AFM module was used.
The AFM system was mounted over an optical inverted microscope
(Nikon-Eclipse).
4.2.1. Tip Calibration. AFM measurements were performed using a
PNP-TR probe (NanoAndMore, Switzerland), tip A. This probe and
tip were selected because of the low force constant (0.32 N·m−1),
adequate soft materials, and its quadratic pyramidal shape (3.5 μm
high, <10 nm diameter) that allows a high resolution. The
experimental spring constant of each tip used was empirically
determined after a force spectroscopy measurement on a glass
coverslip by the thermal noise method before every set of
measurements.53
4.2.2. Microcapsule Sample Preparation. For AFM measurements
in the liquid, capsules needed to be immobilized within a mesh. A
nylon mesh with 330 μm openings (Labopolis S.L.) was glued to a
Petri dish (TPP Techno Plastic Products AG, 93040) bottom using a
standard two-component cyanoacrylate adhesive. Once dried, the
Petri dish was carefully filled with serum-free Dulbecco’s modified
Eagle medium (Cultek, 12-707F), and bubbles were dislodged from
the mesh by gentle pipetting. The dish was then placed and secured
on a Petri dish heater (JPK instruments) assembled onto the
microscope stage and incubated for 15 min to achieve a constant
temperature of 37 °C.
A 300 μL-volume aliquot of the microcapsule sample was obtained
under sterile conditions and gently resuspended using a specialty wide
orifice tip (Sigma-Aldrich, P6800). Then, 50 μL of capsule suspension
was added to the Petri dish and allowed to settle in the mesh openings
for 5 min.
To perform the control AFM measurements of GO particles, the
particles needed to be deposited on a surface for adequate
immobilization that allowed FSBI. To this end, the GO suspension
was diluted by 1:100 in distilled water and a thin layer of the
suspension was pipetted on a glass coverslip. The coverslip was then
immobilized on a Petri dish using a small droplet of water to leverage
capillary force immobilization of the coverslip. The prepared sample
was then imaged in air after calibration of the PNP-TR tip in air, using
the same settings as utilized for the microcapsule FSBI. Because the
particles were relatively big (1535.33 ± 435.31 nm),7 as compared to
the detection range of AFM (usually in the 100 nm range), it is
unlikely that our stiffness measurements were affected by the substrate
on which particles were deposited.
4.2.3. Force Spectroscopy-Based AFM Imaging (Quantitative
Imaging). Force spectroscopy-based imaging was performed as
previously described.22 Briefly, the calibrated cantilever approached
toward the center of an immobilized microcapsule. Initially,
quantitative imaging (QI) maps were obtained using high Z-lengths
and slow speeds (10 μm·s−1), to achieve stable measurements with a
high signal/noise ratio. Then, speed was progressively increased up to
120 μm·s−1 and Z-length was decreased to the nm scale, but
programmed to at least double the image height to minimize the
sample drift effects during the acquisition. To increase resolution, the
piezo range was also limited to 5 μm. At least three capsules of each
type were analyzed with at least five square images (256 × 256 pixels
and 9 μm2) acquired per capsule. Large overview images (100 μm2)
were also taken to verify the homogeneity of the microcapsule surface.
4.2.4. AFM Image Processing. Images were processed with DP
software (JPK Instruments, Germany). Images were first flattened
using a second-order polynomial line fit to highlight smaller features
from the overall curvature of the spherical sample. A low degree
smoothing effect was applied to render pixel transition less evident.
Finally, a gold color scale was applied to all topography images, and a
blue color scale was applied to the stiffness images.
4.3. Microcapsule Constriction Assay. Microcapsule constric-
tion was performed using a custom-made methacrylate microfluidic
device, similar to a previously described system for microcapsule
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aspiration assay.37,38 The device was designed by BeOnChip S.L.
(Spain) and manufactured by Aitiip Centro Tecnoloǵico (Spain). The
microdevice consists of a single 400 μm tubular channel, which is
reduced to 200 μm (schematic of the device and dimensions are
shown in Figure 5). The tube was manufactured via CNC milling of a
10 mm-thick methacrylate plate using a two-sided milling technique.
On one end, a 5 mm channel was milled using a 0.4 mm end mill.
Then, a concentric 3 mm-long channel was milled using a 14″ × 28
UNF end mill to allow screw-on tubing connection to the device.
From the other side of the plate, a concentric tubular channel was
milled using a 0.2 mm end mill, connecting the channels on opposing
sides. The same 14″ × 28 UNF end mill was used on the second side
to generate a screw-on end. Finally, a 3 mm end mill was used for
machining the exterior of the microdevice. For the constriction assays,
the microdevice was connected to a pressure controller (OB1
Microfluidic Flow Control System, Elveflow) using a 1/16″OD PTFE
(Elveflow) and TYGON (Saint-Gobain, ACF00002-C) tubing
systems. The microdevice was placed in an optical inverted
microscope (Leica DMi8) for inspection.
4.3.1. Microcapsule Constriction Measurements. The micro-
capsules were diluted in DPBS. Each single microcapsule was placed
in a U-shaped 96-well plate (Sarstedt) for optical microscopy
inspection (Nikon-Eclipse Ti-E). Microcapsule diameters were
measured with NIS Elements analysis software (Nikon) for future
stiffness calculations. The constriction device was perfused with DPBS
prior to the injection of each single microcapsule in the system.
Pressure was slowly increased to 1000 Pa to position the microcapsule
at the entrance of the microdevice constriction channel, avoiding
mechanical damage. Once the microsphere was correctly located and
blocked the flow pass, the pressure was increased at a constant rate of
100 Pa·s−1, causing the microcapsule to partially penetrate inside the
constriction channel. This process was video-recorded, along with
pressure measurements, for posterior analysis (example in Video S1).
After forcing the microcapsule to go through the constricted channel,
it was collected downstream in a 24-well plate to check its integrity
optically. At least 10 microcapsules per composition were tested.
4.4. Data Processing. 4.4.1. Bidimensional Statistics. Bidimen-
sional statistical quantities (i.e., Ra, RMS, skewness, median image
height, and maximum image height) were calculated using Gwyddion
open-source software.54
4.4.2. Young’s Moduli Extraction. Young’s Moduli were extracted
from nanoindentation curves acquired as pixels for the QI images.
Curves were processed with DP software (JPK Instruments,
Germany) and fitted to a Hertz model modified for quadratic
pyramid indentors.41 The Poisson ratio was set to 0.5. Calculated
values were represented in a map form, and a blue color scale was
applied to all Young’s moduli images. A representative force curve
with the Hertz model fitting and a representative histogram of the
values from a stiffness map are presented in Figure S7.
4.4.3. Correlation Analysis of Topographical and Stiffness
Images. Colocalization studies of topography (gold) and stiffness
(blue) maps were performed using the Van Steensel procedure in
ImageJ as previously described.22,55,56 Briefly, images were converted
into 16-bit binary format. For a clear representation of colocalizing
features, topography images were depicted in red and topography
maps in green. Pearson moment−product correlation rρ was
calculated and plotted against Δx. Average correlation curves +
SEM were generated from at least five pairs of topography/stiffness
images. Spatial Pearson moment−product correlations were com-
pared to 0 in the central point via one-sample t-tests.
4.4.4. Stiffness Calculation from Constriction Data. The
microcapsule stiffness was calculated as a pressure/deformation
relationship (ΔP/Δδ), where the deformation was identified by the
penetration length percentage over the initial microcapsule diameter
(Figure 5). Experimental videos were recorded simultaneously to the
variation of the fluid pressure for each tested capsule (example in
Video S1). The frames corresponding to discrete pressure values were
exported as image files (VLC media player software). The
microcapsule penetration distance in the small-diameter channel
was measured using image analysis (ImageJ). The experimental results
were fitted to a pressure/deformation curve, as previously reported for
the mechanical characterization of capsules via aspiration assays.38
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(39) Cañibano-Hernańdez, A.; Saenz del Burgo, L.; Espona-
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